Studying the immune response and long-term morbidity of COVID-19 infection in pregnancy

Not Applicable

Completed

• Conditions: COVID-19 (SARS-CoV-2 infection) in pregnant women; Infections and Infestations

• Registration Number: ISRCTN93266696
• Lead Sponsor: Queen Mary University of London

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-06-11
• Study Completion: 2022-11-11
• Last Update Posted: 28 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

1. Pregnant women who are admitted to the hospital and have suspected (symptomatic) or confirmed COVID-19 infection and up to 2 weeks post-delivery
2. Age =18 years

Note that women admitted for any reason, including non-COVID-19 related reasons such as obstetric reasons, will be included.

Pregnant women may also be identified via the COVIDENCE-UK study (NCT04330599), a national observational cohort study of individuals enrolled from the community that can be potentially diagnosed with COVID-19.

Exclusion Criteria

1. Patients unwilling to give consent
2. Unable to understand sufficient English, and no translator or translation services are available

Study & Design

• Study Type: Observational
• Study Design: Not specified